Finance

Lists
Why is 300558 down 2,85%?
Dive Deeper
300558:SHE
Betta Pharmaceuticals Co Ltd
41,99 CN¥
-2,85%
(-1,23) 1D
15 қаз., 15:04:34 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300558...
Open
42,68 CN¥
High
44,24 CN¥
Low
41,81 CN¥
Mkt. cap
19,08 млрд
Avg. vol.
10,42 млн
Volume
11,13 млн
Dividend
0,36%
Quarterly dividend
0,04 CN¥
Ex-dividend date
2026 ж. 09 мау.
P/E ratio
37,73
52-wk high
78,18 CN¥
52-wk low
40,10 CN¥
EPS
1,11 CN¥
Shares outstanding
423,33 млн
No. of employees
2 мың
Open
42,68 CN¥
High
44,24 CN¥
Low
41,81 CN¥
Mkt. cap
19,08 млрд
Avg. vol.
10,42 млн
Volume
11,13 млн
Dividend
0,36%
Quarterly dividend
0,04 CN¥
Ex-dividend date
2026 ж. 09 мау.
P/E ratio
37,73
52-wk high
78,18 CN¥
52-wk low
40,10 CN¥
EPS
1,11 CN¥
Shares outstanding
423,33 млн
No. of employees
2 мың
News stories
From web sources and news partners
About Betta Pharmaceuticals Co Ltd
CEO-
Employees1,78 мың
Founded2003 ж. 07 қаң.
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
985,93 млн
892,00 млн
1,04 млрд
936,09 млн
Cost of goods sold
208,48 млн
204,34 млн
217,50 млн
248,14 млн
Cost of revenue
208,48 млн
204,34 млн
217,50 млн
248,14 млн
Research and development expenses
118,31 млн
137,90 млн
97,44 млн
119,49 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
447,07 млн
477,36 млн
422,85 млн
465,85 млн
Operating expense
578,16 млн
625,07 млн
526,01 млн
606,92 млн
Total operating expenses
786,65 млн
829,41 млн
743,50 млн
855,05 млн
Operating income
199,28 млн
62,58 млн
296,33 млн
81,04 млн
Other non operating income
-8,80 млн
6,81 млн
-10,30 млн
8,81 млн
EBT including unusual items
203,76 млн
22,79 млн
282,47 млн
85,85 млн
EBT excluding unusual items
181,48 млн
38,51 млн
268,61 млн
54,28 млн
Income tax expense
31,46 млн
39,59 млн
51,31 млн
24,32 млн
Effective tax rate
15,44%
173,71%
18,16%
28,33%
Other operating expenses
13,08 млн
9,32 млн
6,34 млн
16,52 млн
Net income
177,04 млн
-11,60 млн
235,92 млн
66,22 млн
Net profit margin
17,96%
-1,30%
22,69%
7,07%
Earnings per share
-
-
-
-
Interest and investment income
862,68 м.
369,02 м.
564,57 м.
445,21 м.
Interest expense
-18,62 млн
-18,62 млн
-17,98 млн
-18,50 млн
Net interest expenses
-17,76 млн
-18,25 млн
-17,41 млн
-18,05 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
291,32 млн
199,56 млн
433,31 млн
220,30 млн
Gain or loss from assets sale
72,94 мың
-377,65 м.
-
344,11 м.
AI content may include mistakes. Learn more
Google қолданбалары